Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients
Study Details
Study Description
Brief Summary
This study was a survey to determine the frequency of Complementary and Alternative Medicine (CAM) use in patients recently diagnosed with breast or prostate cancer who were starting radiation therapy. The survey was repeated at three time points to assess changes in CAM use over time.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Outcome Measures
Primary Outcome Measures
- Quantitate the various types of CAM therapy utilized by men with prostate cancer and women with breast cancer who are currently undergoing radiation. [Up to 1 year]
Quantitate the various types of CAM therapy utilized by men with prostate cancer and women with breast cancer who are currently undergoing radiation therapy at The James Cancer Hospital and Solove Research Institute. Nutrient supplements and alternative medication use is the primary focus of the assessment.
- Determine if patients change their patterns of CAM use prior to, during, or after radiation treatment. [Up to 1 year]
- Assess quality of life using validated instruments during radiation therapy and determine if there is a correlation between CAM use and quality of life. [Up to 1 year]
- Assess radiation therapy toxicity using standardized criteria from the Oncology Nursing Society and determine if there is a correlation between CAM use and measures of toxicity. [Up to 1 year]
- To determine predictive factors for CAM and nutritional supplement use, such as age, race, income, education, marital status, or tobacco/alcohol use. [Up to 1 year]
Eligibility Criteria
Criteria
Inclusion/Exclusions
-
Men that have histologically proven carcinoma of the prostate and have chosen some form of radiation therapy as their primary therapy for prostate cancer.
-
Women who are undergoing external beam radiation therapy to the breast as primary or adjuvant therapy are eligible.
-
All participants must be able to read and write.
-
Subjects with dementia and mental retardation that complicates completing the questionnaires will not be enrolled.
-
Subjects with known metastatic disease will be excluded.
-
There are no age restrictions for this study.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Ohio State University Comprehensive Cancer Center | Columbus | Ohio | United States | 43210 |
Sponsors and Collaborators
- Ohio State University Comprehensive Cancer Center
- National Center for Complementary and Integrative Health (NCCIH)
Investigators
- Principal Investigator: Steven Clinton, MD, Ohio State University Comprehensive Cancer Center
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- OSU-0240